Additional funding for inmate pharmaceuticals

Last Updated:	2/9/2012
Budget Issue:	Additional funding for inmate pharmaceuticals
Program:	Department of Corrections and Rehabilitation
Finding or Recommendation:	Reduce the proposed General Fund augmentation by $20 million to an augmentation of $39.9 million in 2012-13 and $31.2 million in 2013-14 to account for additional efficiencies we believe could be achieved from better inventory management and reduced use of non-formulary drugs. Approve this augmentation for two years only so that the need for ongoing funding in future years can be reevaluated.